88 related articles for article (PubMed ID: 1712134)
1. Intraoperative use of aprotinin (Trasylol) in orthotopic liver transplantation.
Mallett S; Rolles K; Cox D; Burroughs A; Hunt B
Transplant Proc; 1991 Jun; 23(3):1931-2. PubMed ID: 1712134
[No Abstract] [Full Text] [Related]
2. Fibrinolytic changes and the influence of the early perfusate in orthotopic liver transplantation with intraoperative aprotinin treatment.
Himmelreich G; Kierzek B; Neuhaus P; Slamer KJ; Riess H
Transplant Proc; 1991 Jun; 23(3):1936-7. PubMed ID: 1712137
[No Abstract] [Full Text] [Related]
3. Aprotinin inhibits tissue plasminogen activator-mediated fibrinolysis during orthotopic liver transplantation.
Cottam S; Hunt B; Segal H; Ginsburg R; Potter D
Transplant Proc; 1991 Jun; 23(3):1933. PubMed ID: 1712135
[No Abstract] [Full Text] [Related]
4. Does aprotinin really reduce blood loss in orthotopic liver transplantation?
Groh J; Welte M; Azad SC; Anthuber M; Haller M; Kratzer MA
Semin Thromb Hemost; 1993; 19(3):306-8. PubMed ID: 7689758
[No Abstract] [Full Text] [Related]
5. In vitro study of the effects of aprotinin on coagulation during orthotopic liver transplantation.
Kang Y; De Wolf AM; Aggarwal S; Campbell E; Martin LK
Transplant Proc; 1991 Jun; 23(3):1934-5. PubMed ID: 1712136
[No Abstract] [Full Text] [Related]
6. Aprotinin in orthotopic liver transplantation.
Bechstein WO; Riess H; Blumhardt G; Himmelreich G; Jochum M; Gerlach H; Rossaint R; Keck H; Neuhaus P
Semin Thromb Hemost; 1993; 19(3):262-7. PubMed ID: 7689751
[No Abstract] [Full Text] [Related]
7. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.
Ickx BE; van der Linden PJ; Melot C; Wijns W; de Pauw L; Vandestadt J; Hut F; Pradier O
Transfusion; 2006 Apr; 46(4):595-605. PubMed ID: 16584436
[TBL] [Abstract][Full Text] [Related]
8. Aprotinin in orthotopic liver transplantation.
García L; Sabaté A; Domenech P; Martinez Brotons F; Drudis R; Jaurrieta E
Transplant Proc; 1995 Aug; 27(4):2290-1. PubMed ID: 7544500
[No Abstract] [Full Text] [Related]
9. The intra-operative use of trasylol (aprotinin) in liver transplantation.
Mallett SV; Cox D; Burroughs AK; Rolles K
Transpl Int; 1991 Dec; 4(4):227-30. PubMed ID: 1723874
[TBL] [Abstract][Full Text] [Related]
10. Aprotinin in orthotopic liver transplantation: evidence for a prohemostatic, but not a prothrombotic, effect.
Molenaar IQ; Legnani C; Groenland TH; Palareti G; Begliomini B; Terpstra OT; Porte RJ
Liver Transpl; 2001 Oct; 7(10):896-903. PubMed ID: 11679989
[TBL] [Abstract][Full Text] [Related]
11. Pro: Antifibrinolytics are safe and effective in patients undergoing liver transplantation.
Lerner AB
J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):888-90. PubMed ID: 17138101
[No Abstract] [Full Text] [Related]
12. Con: Antifibrinolytics are not safe and effective in patients undergoing liver transplantation.
Ramsay MA
J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):891-3. PubMed ID: 17138102
[No Abstract] [Full Text] [Related]
13. Influence of high-dose aprotinin on hemostasis and blood requirement in orthotopic liver transplantation.
Grosse H; Lobbes W; Frambach M; Ringe B; Barthels M
Semin Thromb Hemost; 1993; 19(3):302-5. PubMed ID: 7689757
[No Abstract] [Full Text] [Related]
14. Impact of aprotinin on blood transfusion requirements in liver transplantation.
Smith O; Hazlehurst G; Brozovic B; Rolles K; Burroughs A; Mallett S; Dawson K; Mehta A
Transfus Med; 1993 Jun; 3(2):97-102. PubMed ID: 7690641
[TBL] [Abstract][Full Text] [Related]
15. [Aprotinin in orthotopic liver transplantation].
García Huete L; Sabaté Pes A
Med Clin (Barc); 1997 Mar; 108(11):439. PubMed ID: 9213647
[No Abstract] [Full Text] [Related]
16. Factor XIII activity during orthotopic liver transplantation.
Himmelreich G; Müller C; Isenberg C; Bechstein WO; Roissant R; Riess H
Semin Thromb Hemost; 1993; 19(3):243-5. PubMed ID: 7689750
[No Abstract] [Full Text] [Related]
17. Effect of two different dosages of aprotonin on perioperative blood loss during liver transplantation.
Ickx B; Pradier O; DeGroote F; Hendrice C; Toungouz M; Vandestadt J; Gelin M; Capel P
Semin Thromb Hemost; 1993; 19(3):300-1. PubMed ID: 7689756
[No Abstract] [Full Text] [Related]
18. Aprotinin reduces the need for blood products during liver transplantation.
Scudamore CH; Randall TE; Jewesson PJ; Shackleton CR; Salvian AJ; Fagan M; Frighetto L; Growe GH; Scarth I; Erb SR
Am J Surg; 1995 May; 169(5):546-9. PubMed ID: 7538269
[TBL] [Abstract][Full Text] [Related]
19. Aprotinin and nafamostat mesilate in liver surgery: effect on blood loss.
Pereboom IT; de Boer MT; Porte RJ; Molenaar IQ
Dig Surg; 2007; 24(4):282-7. PubMed ID: 17657153
[TBL] [Abstract][Full Text] [Related]
20. The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study.
Dalmau A; Sabaté A; Koo M; Bartolomé C; Rafecas A; Figueras J; Jaurrieta E
Liver Transpl; 2004 Feb; 10(2):279-84. PubMed ID: 14762867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
